Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
23.70
-0.70 (-2.87%)
At close: Mar 10, 2026

HKG:2591 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023
Period Ending
Mar '26 Dec '24 Dec '23
Debt / Equity Ratio
0.080.010.07
Net Debt / Equity Ratio
-0.99-0.99-0.92
Net Debt / EBITDA Ratio
3.024.500.88
Net Debt / FCF Ratio
3.884.723.67
Quick Ratio
3.365.821.94
Current Ratio
3.556.072.66
Return on Equity (ROE)
--23.27%-
Return on Assets (ROA)
--11.61%-
Return on Capital Employed (ROCE)
-33.70%-23.80%-100.30%
Buyback Yield / Dilution
--9.63%-
Source: S&P Capital IQ. Standard template. Financial Sources.